Which has the lower trailing P/E, ABBV or GILD?

GILD has the lower trailing P/E: ABBV trades at 129.20 and GILD at 18.30. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or GILD?

Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus GILD at 3.07%.

Does ABBV or GILD pay a bigger dividend?

ABBV yields 2.56% and GILD yields 2.40% based on trailing dividends and the latest price.

Is ABBV or GILD more profitable?

GILD runs the higher net margin — ABBV at 5.79% versus GILD at 30.99%.

How have ABBV and GILD total returns compared?

Over the past 10 years, ABBV delivered 19.90% and GILD delivered 8.95% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Gilead Sciences, Inc. (GILD)

A side-by-side comparison of AbbVie Inc. and Gilead Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$465.69B

$263.58HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT

GILD

Gilead Sciences, Inc.

$164.79B

$132.73HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT

Total return — ABBV vs GILD

growth of $100 · dividends reinvested · last 14y

ABBV +1197.1%GILD +427.2%ABBV compounded faster

ABBV GILD

ABBV vs GILD: by the numbers

•ABBV is the larger company ($465.69B vs $164.79B market cap).
•GILD trades at the lower trailing earnings multiple (18.30 vs 129.20 P/E), one valuation lens rather than an overall verdict.
•GILD converts more revenue to profit (30.99% vs 5.79% net margin).
•ABBV grew revenue faster over the past five years (4.59% vs 3.07% CAGR).
•ABBV pays the higher dividend yield (2.56% vs 2.40%).

Metrics side by side

Valuation

Metric	ABBV	GILD
P/E ratio	129.20	18.30
P/S ratio	7.44	5.66
P/B ratio	17.00	7.16
PEG ratio	N/A	0.01
EV / EBITDA	20.92	12.95
FCF yield	4.46%	6.07%

Profitability

Metric	ABBV	GILD
Gross margin	70.68%	79.35%
Operating margin	27.60%	38.26%
Net margin	5.79%	30.99%
ROE	13.23%	39.19%
ROIC	12.97%	21.53%

Dividends

Metric	ABBV	GILD
Dividend yield	2.56%	2.40%
Payout ratio	284.39%	47.08%

Growth (annualized)

Metric	ABBV	GILD
Revenue CAGR (5Y)	4.59%	3.07%
EPS CAGR (5Y)	-2.79%	133.83%
FCF CAGR (5Y)	3.24%	3.30%
Total return CAGR (5Y)	21.73%	18.12%

Frequently asked

Which has the lower trailing P/E, ABBV or GILD?: GILD has the lower trailing P/E: ABBV trades at 129.20 and GILD at 18.30. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or GILD?: Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus GILD at 3.07%.
Does ABBV or GILD pay a bigger dividend?: ABBV yields 2.56% and GILD yields 2.40% based on trailing dividends and the latest price.
Is ABBV or GILD more profitable?: GILD runs the higher net margin — ABBV at 5.79% versus GILD at 30.99%.
How have ABBV and GILD total returns compared?: Over the past 10 years, ABBV delivered 19.90% and GILD delivered 8.95% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full GILD analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Gilead Sciences P/E ratio AbbVie dividend yield Gilead Sciences dividend yield AbbVie ROE Gilead Sciences ROE AbbVie operating margin Gilead Sciences operating margin AbbVie revenue growth Gilead Sciences revenue growth AbbVie free cash flow Gilead Sciences free cash flow

AbbVie & Gilead Sciences appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.